Nuzenio

Cancer Therapy Benzinga

Cancer Therapy Benzinga entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 11 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Silence Therapeutics Says Blood Cancer Trial Delivers 'Best-Case Outcome' - BenzingaBenzinga · Mon, 10 Aug 2026 14:15:58 GMTInnate Pharma Jumps as Sobi Deal Boosts Secured Financing for Advancing Rare Skin Cancer Therapy - BenzingaBenzinga · Mon, 10 Aug 2026 14:03:30 GMTTwo Rejections, Messy Process: Replimune Finally Secures FDA Approval for Skin Cancer Treatment - BenzingaBenzinga · Fri, 07 Aug 2026 11:49:41 GMTVERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-G - BenzingaBenzinga · Thu, 06 Aug 2026 16:27:24 GMTAutonomix Stock Skyrockets After Obtaining Key Cancer Tech Patent - BenzingaBenzinga · Tue, 04 Aug 2026 19:27:25 GMTAstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger - BenzingaBenzinga · Sun, 02 Aug 2026 20:12:52 GMTReplimune Skin Cancer Therapy Hopes Revive After Positive FDA Panel Vote - BenzingaBenzinga · Fri, 31 Jul 2026 14:09:17 GMTKaryopharm Stock (KPTI) Crashes After Hours: Here's What's Driving the Move - BenzingaBenzinga · Fri, 31 Jul 2026 07:00:00 GMT

Timeline

Mon, 10 Aug 2026 14:15:58 GMTSilence Therapeutics Says Blood Cancer Trial Delivers 'Best-Case Outcome' - Benzinga
Mon, 10 Aug 2026 14:03:30 GMTInnate Pharma Jumps as Sobi Deal Boosts Secured Financing for Advancing Rare Skin Cancer Therapy - Benzinga
Fri, 07 Aug 2026 11:49:41 GMTTwo Rejections, Messy Process: Replimune Finally Secures FDA Approval for Skin Cancer Treatment - Benzinga
Thu, 06 Aug 2026 16:27:24 GMTVERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-G - Benzinga
Tue, 04 Aug 2026 19:27:25 GMTAutonomix Stock Skyrockets After Obtaining Key Cancer Tech Patent - Benzinga
Sun, 02 Aug 2026 20:12:52 GMTAstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger - Benzinga

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Cancer Therapy Benzinga.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.